$0.0500
0.0524900.00%
At close: -
Comments
Loading...
Vaxxinity Analyst Ratings and Price Targets | OTC:VAXX | Benzinga
Vaxxinity Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Vaxxinity Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
1calculated from analyst ratings
Analyst Ratings for Vaxxinity
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 09/08/2023 | Buy Now | — | Baird | Joel Beatty69% | → $7 | Initiates | → Outperform | Get Alert |
| 04/27/2022 | Buy Now | — | Evercore ISI Group | Jonathan Miller10% | — | Initiates | → In-Line | Get Alert |
FAQ
What is the target price for Vaxxinity (VAXX) stock?
The latest price target for Vaxxinity (OTCEM:VAXX) was reported by Baird on September 8, 2023. The analyst firm set a price target for $7.00 expecting VAXX to rise to within 12 months (a possible 13900.00% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vaxxinity (VAXX)?
The latest analyst rating for Vaxxinity (OTCEM:VAXX) was provided by Baird, and Vaxxinity initiated their outperform rating.
When was the last upgrade for Vaxxinity (VAXX)?
There is no last upgrade for Vaxxinity
When was the last downgrade for Vaxxinity (VAXX)?
There is no last downgrade for Vaxxinity.
When is the next analyst rating going to be posted or updated for Vaxxinity (VAXX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxxinity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxxinity was filed on September 8, 2023 so you should expect the next rating to be made available sometime around September 8, 2024.
Is the Analyst Rating Vaxxinity (VAXX) correct?
While ratings are subjective and will change, the latest Vaxxinity (VAXX) rating was a initiated with a price target of $0.00 to $7.00. The current price Vaxxinity (VAXX) is trading at is $0.05, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.